PRLB vs VTRS · P/E 75, $1.89B cap vs rev $14.74B
Proto Labs Inc (PRLB) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Proto Labs Inc (PRLB) is a metal fabrication company listed on NYSE.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
PRLB does not have a complete income-statement cache yet.
Latest reported VTRS revenue for 2024-12-31 was $14.74B. Net income was -$634.2M. Revenue was down 4.5% from 2023-12-31 to 2024-12-31. VTRS currently screens at market cap $10.83B.
PRLB currently screens at market cap $1.89B and trailing P/E 75.1. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the PRLB and VTRS stock pages for the full models.
Not investment advice.